Document:

Exhibit 10.6

 

[Form Stock Escrow Agreement]

 

STOCK ESCROW AGREEMENT

 

STOCK ESCROW AGREEMENT,
dated as of March [•], 2020 (“Agreement”), by and among NOVUS CAPITAL CORPORATION, a Delaware corporation (“Company”),
the stockholders of the Company listed on Exhibit A hereto (the “Founders”) and CONTINENTAL STOCK TRANSFER & TRUST
COMPANY, a New York corporation (“Escrow Agent”).

 

WHEREAS, the Company
was formed for the purpose of completing a merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization
or other similar business combination (a “Business Combination”) with one or more businesses or entities.

 

WHEREAS, the
Company has entered into an Underwriting Agreement, dated [•], 2020 (“Underwriting Agreement”),
with EARLYBIRDCAPITAL, INC. (the “Representative”)
acting as representative of the several underwriters (collectively, the “Underwriters”), pursuant to which, among
other matters, the Underwriters have agreed to purchase 10,000,000 units (“Units”) of the Company, plus an
additional 1,500,000 Units if the Representative exercises the over-allotment option in full. Each Unit consists of one share
of the Company’s common stock, par value $0.0001 per share (“Common Stock”), and three-quarters of one
warrant (“Warrant”), each whole Warrant to purchase one share of Common Stock, all as more fully described in the
Company’s final Prospectus, dated [•], 2020 (“Prospectus”) comprising part of the Company’s
Registration Statement on Form S-1 (File No. 333-[•]) under the Securities Act of 1933, as amended (“Registration
Statement”), declared effective on [•], 2020 (“Effective Date”).

 

WHEREAS, the Founders
have agreed as a condition of the sale of the Units to deposit their shares of Common Stock of the Company in escrow as hereinafter
provided.

 

WHEREAS, the Company
and the Founders desire that the Escrow Agent accept the shares of Common Stock, in escrow, to be held and disbursed as hereinafter
provided.

 

IT IS AGREED:

 

1. Appointment
of Escrow Agent. The Company and the Founders hereby appoint the Escrow Agent to act in accordance with and subject to the
terms of this Agreement and the Escrow Agent hereby accepts such appointment and agrees to act in accordance with and subject to
such terms.

 

2. Deposit
of Shares. On or before the Effective Date, the Founders’ respective shares of Common Stock set forth on Exhibit A hereto
shall be deposited in escrow, to be held and disbursed subject to the terms and conditions of this Agreement. The Founders acknowledge
that the shares deposited in escrow will be legended to reflect the deposit of such shares under this Agreement.

 

3. Disbursement
of the Escrow Shares.

 

3.1 If the over-allotment
option to purchase all or a portion of the additional 1,500,000 Units of the Company is not exercised in full within 45 days of
the date of the Prospectus (as described in the Underwriting Agreement), the Founders agree that the Escrow Agent shall return
to the Company for cancellation, at no cost, the number of shares of Common Stock determined by multiplying 375,000 by a fraction,
(i) the numerator of which is 1,500,000 minus the number of shares of Common Stock included in the Units purchased by the Underwriters
upon the exercise of the over-allotment option, and (ii) the denominator of which is 1,500,000. The Company shall promptly provide
notice to the Escrow Agent of the expiration or termination of the over-allotment option and the number of Units, if any, purchased
by the Underwriters in connection with the exercise thereof.

 

3.2 Except as otherwise
set forth herein, the Escrow Agent shall hold the shares remaining after any cancellation required pursuant to Section 3.1 above
(such remaining shares to be referred to herein as the “Escrow Shares”) until (i) with respect to 50% of the Escrow
Shares, the earlier of (x) one year after the date of the consummation of an initial Business Combination and (y) the date on which
the last sale price of the Common Stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations
and recapitalizations) for any 20 trading days within any 30-trading day period following the consummation of the Business Combination
and (ii) with respect to the remaining 50% of the Escrow Shares, one year after the date of the consummation of an initial Business
Combination (such period of time during which the Escrow Shares are held in escrow, the “Escrow Period”). The Company
shall promptly provide notice of the consummation of an initial Business Combination to the Escrow Agent. Upon completion of the
Escrow Period, the Escrow Agent shall disburse such amount of each Founder’s Escrow Shares to the applicable Founder; provided,
however, that if, after the consummation of an initial Business Combination and during the Escrow Period, the Company (or the surviving
entity) consummates a liquidation, merger, stock exchange or other similar transaction which results in all of the stockholders
of such entity having the right to exchange their shares of Common Stock for cash, securities or other property, then the Escrow
Agent will, upon receipt of a notice executed by the Chairman of the Board, Chief Executive Officer or other authorized officer
of the Company, in form reasonably acceptable to the Escrow Agent, certifying that such transaction is then being consummated or
such conditions have been achieved, as applicable, release the Escrow Shares to the Founders. The Escrow Agent shall have no further
duties hereunder after the disbursement of the Escrow Shares in accordance with this Section 3.2.

 

     

     

    

 

3.3 If the Escrow
Agent is notified by the Company pursuant to Section 6.7 hereof that the Company’s Trust Account (as defined in that certain
Investment Management Trust Agreement, dated as of the date hereof, by and between the Company and the Escrow Agent as trustee
thereunder) is being liquidated, then the Escrow Agent shall deliver the certificates representing the Escrow Shares to the Founders
promptly after the public stockholders are paid the liquidating distributions and shall have no further duties hereunder.

 

4. Rights of
Founders in Escrow Shares.

 

4.1 Voting Rights
as a Stockholder. Subject to the terms of the Insider Letters described in Section 4.4 hereof and except as herein provided,
the Founders shall retain all of their rights as stockholders of the Company as long as any shares are held in escrow pursuant
to this Agreement, including, without limitation, the right to vote such shares.

 

4.2 Dividends
and Other Distributions in Respect of the Escrow Shares. For as long as any shares are held in escrow pursuant to this Agreement,
all dividends payable in cash with respect to the Escrow Shares shall be paid to the Founders, but all dividends payable in stock
or other non-cash property (“Non-Cash Dividends”) shall be delivered to the Escrow Agent to hold in accordance with
the terms hereof. As used herein, the term “Escrow Shares” shall be deemed to include the Non-Cash Dividends distributed
thereon, if any.

 

4.3 Restrictions
on Transfer. During the Escrow Period, the only permitted transfers of the Escrow Shares will be (i) to the Founders and the
Company’s officers, directors, consultants or their affiliates, (ii) to a Founder’s stockholders, partners or members
upon such Founder’s liquidation, (iii) by bona fide gift to a member of the Founders’ immediate family or to a trust,
the beneficiary of which is a Founder or a member of a Founder’s immediate family for estate planning purposes, (iv) by virtue
of the laws of descent and distribution upon death of a Founder, (v) pursuant to a qualified domestic relations order binding on
a Founder, (vi) to the Company for no value for cancellation in connection with the consummation of a Business Combination or (vii)
by private sales of the Escrow Shares made at or prior to the consummation of a Business Combination at prices no greater than
the price at which the Escrow Shares were originally purchased; provided, however, that except for clause (vi) or with the Company’s
prior written consent, such permitted transfers may be implemented only upon the respective transferee’s written agreement
to be bound by the terms and conditions of this Agreement and of the Insider Letter signed by the Founder transferring the shares.

 

4.4 Insider Letters.
The Founders have executed letter agreements with the Company and the Representative, dated as of the date hereto, the form of
which is filed as an exhibit to the Registration Statement (“Insider Letter”), respecting the rights and obligations
of such Founders in certain events, including, but not limited to, the liquidation of the Company.

 

5. Concerning
the Escrow Agent.

 

5.1 Good Faith
Reliance. The Escrow Agent shall not be liable for any action taken or omitted by it in good faith and in the exercise of its
own best judgment, and may rely conclusively and shall be protected in acting upon any order, notice, demand, certificate, opinion
or advice of counsel (including counsel chosen by the Escrow Agent), statement, instrument, report or other paper or document (not
only as to its due execution and the validity and effectiveness of its provisions, but also as to the truth and acceptability of
any information therein contained) which is believed by the Escrow Agent in good faith to be genuine and to be signed or presented
by the proper person or persons. The Escrow Agent shall not be bound by any notice or demand, or any waiver, modification, termination
or rescission of this Agreement unless evidenced by a writing delivered to the Escrow Agent signed by the proper party or parties
and, if the duties or rights of the Escrow Agent are affected, unless it shall have given its prior written consent thereto.

 

    	 	2	 

     

    

 

5.2 Indemnification.
Subject to Section 5.8 below, the Escrow Agent shall be indemnified and held harmless by the Company from and against any expenses,
including reasonable counsel fees and disbursements, or loss suffered by the Escrow Agent in connection with any action, suit or
other proceeding involving any claim which in any way, directly or indirectly, arises out of or relates to this Agreement, the
services of the Escrow Agent hereunder, or the Escrow Shares held by it hereunder, other than expenses or losses arising from the
gross negligence, fraud or willful misconduct of the Escrow Agent. Promptly after the receipt by the Escrow Agent of notice of
any demand or claim or the commencement of any action, suit or proceeding, the Escrow Agent shall notify the other parties hereto
in writing. In the event of the receipt of such notice, the Escrow Agent, in its sole discretion, may commence an action in the
nature of interpleader in an appropriate court to determine ownership or disposition of the Escrow Shares or it may deposit the
Escrow Shares with the clerk of any appropriate court or it may retain the Escrow Shares pending receipt of a final, non-appealable
order of a court having jurisdiction over all of the parties hereto directing to whom and under what circumstances the Escrow Shares
are to be disbursed and delivered. The provisions of this Section 5.2 shall survive in the event the Escrow Agent resigns or is
discharged pursuant to Sections 5.5 or 5.6 below.

 

5.3 Compensation.
Subject to Section 5.8 below, the Escrow Agent shall be entitled to reasonable compensation from the Company for all services rendered
by it hereunder. The Escrow Agent shall also be entitled to reimbursement from the Company for all reasonable expenses paid or
incurred by it in the administration of its duties hereunder including, but not limited to, all counsel, advisors’ and agents’
fees and disbursements and all taxes or other governmental charges.

 

5.4 Further Assurances.
From time to time on and after the date hereof, the Company and the Founders shall deliver or cause to be delivered to the Escrow
Agent such further documents and instruments and shall do or cause to be done such further acts as the Escrow Agent shall reasonably
request to carry out more effectively the provisions and purposes of this Agreement, to evidence compliance herewith or to assure
itself that it is protected in acting hereunder.

 

5.5 Resignation.
The Escrow Agent may resign at any time and be discharged from its duties as escrow agent hereunder by its giving the other parties
hereto written notice and such resignation shall become effective as hereinafter provided. Such resignation shall become effective
at such time that the Escrow Agent shall turn the Escrow Shares over to a successor escrow agent appointed by the Company and approved
by the Representative, which approval will not be unreasonably withheld, conditioned or delayed. If no new escrow agent is so appointed
within the 60-day period following the giving of such notice of resignation, the Escrow Agent may deposit the Escrow Shares with
any court it reasonably deems appropriate in the State of New York.

 

5.6 Discharge
of Escrow Agent. The Escrow Agent shall resign and be discharged from its duties as escrow agent hereunder if so requested
in writing at any time by all of the other parties hereto; provided, however, that such resignation shall become effective only
upon the appointment of a successor escrow agent selected by the Company and approved by the Representative, which approval will
not be unreasonably withheld, conditioned or delayed.

 

5.7 Liability.
Notwithstanding anything herein to the contrary, the Escrow Agent shall not be relieved from liability hereunder for its own gross
negligence, fraud or willful misconduct.

 

5.8 Waiver.
The Escrow Agent hereby waives any right of set-off or any other right, title, interest or claim of any kind (“Claim”)
in, or to any distribution of, the Trust Account and hereby agrees not to seek recourse, reimbursement, payment or satisfaction
for any Claim against the Trust Account for any reason whatsoever.

 

    	 	3	 

     

    

 

6. Miscellaneous.

 

6.1 Governing
Law. This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York, without
giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction.
The parties hereto consent to the jurisdiction and venue of any state or federal court located in the City of New York, Borough
of Manhattan, for purposes of resolving any disputes hereunder. As to any claim, cross-claim, or counterclaim in any way relating
to this Agreement, each party waives the right to trial by jury.

 

6.2 Third Party
Beneficiaries. Each of the parties to this Agreement hereby acknowledges that the Representative is a third party beneficiary
of this Agreement.

 

6.3 Entire Agreement.
This Agreement contains the entire agreement of the parties hereto with respect to the subject matter hereof and, except as expressly
provided herein, may only be changed, amended, or modified by a writing signed by each of the parties hereto.

 

6.4 Headings.
The headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation
thereof.

 

6.5 Binding Effect.
This Agreement shall be binding upon and inure to the benefit of the respective parties hereto and their legal representatives,
successors and assigns.

 

6.6 Notices.
Any notice, consent or request to be given in connection with any of the terms or provisions of this Agreement shall be in writing
and shall be sent by express mail or similar private courier service, by certified mail (return receipt requested), by hand delivery,
by email or by facsimile transmission:

 

If to the Company, to:

 

Novus Capital Corporation

8556 Oakmont
Lane

Indianapolis,
Indiana 46260

Email: [•]

 

If to a Founder, to his/her/its
address set forth in Exhibit A.

 

and if to the Escrow
Agent, to:

 

Continental Stock Transfer
 & Trust Company

1 State Street

New York, New York
10004

Attn: Chairman

Fax No.:

Email:

 

A copy of any notice
sent hereunder shall be sent to:

 

EarlyBirdCapital,
Inc.

366 Madison
Ave 8th Floor

New York, NY
10017

Attn: Steven
Levine

Fax No.:

Email: slevine@ebccap.com

 

    	 	4	 

     

    

 

with a copy to:

 

Blank Rome LLP

1271 Avenue of the Americas

New York, New York 10020

Attn: Robert J. Mittman, Esq.

Fax No: (917) 332.3800

Email: Rmittman@blankrome.com

 

 and:

 

Graubard Miller

The Chrysler Building

405 Lexington Avenue

New York, New York 10174

Attn: David Alan Miller, Esq.

Fax No.: (212) 818-8881

Email: dmiller@graubard.com

 

The parties may change
the persons and addresses to which the notices or other communications are to be sent by giving written notice to any such change
in the manner provided herein for giving notice.

 

6.7 Liquidation
of the Trust Account. The Company shall give the Escrow Agent written notification of the liquidation of the Trust Account
in the event that the Company fails to consummate a Business Combination within the time period specified in the Company’s
Amended and Restated Certificate of Incorporation, as the same may be amended from time to time.

 

6.8 Counterparts.
This Agreement may be executed in several counterparts, each one of which shall constitute an original and may be delivered by
facsimile transmission and together shall constitute one instrument.

 

 

[Signature Page Follows]

 

    	 	5	 

     

    

 

WITNESS the execution
of this Agreement as of the date first above written.

 

	 	NOVUS CAPITAL CORPORATION
	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 

 

	 	INITIAL STOCKHOLDERS:
	 	 
	 	ROBERT J. LAIKIN
	 	 
	 	 Robert J. Laikin
	 
	 	 
	 	ZAK LAIKIN
	 	 
	 	 Zak Laikin
	 
	 	
         

        Larry Gretchen Paulson
        Trust

	 	 
	 	By:	 
	 	Name:	Larry Paulson
	 	Title:	 

 

	 	NEW FRONTIER LLC
	 	 
	 	By:	 
	 	Name:	Jeffrey Foster
	 	Title:	 
	 	 
	 	HIRSCH FAMILY LIVING TRUST
	 	 
	 	By:	 
	 	Name:	Dan Hirsch
	 	Title:	 
	 	 
	 	MONS INVESTMENT LLC
	 	 
	 	By:	 
	 	Name:	Hersch Klaff
	 	Title:	 

 

	 	CLIFF HOLDINGS LLC
	 	 
	 	By:	 
	 	Name:	Ryan Levy
	 	Title:	 

 

 

[Signature Page to Stock Escrow Agreement]

 

     

     

    

 

	 	VINCE DONARGO
	 	 
	 	 Vince Donargo
	 
	 	 	 
	 	LOUIS CONFORTI
	 	 
	 	Louis Conforti
	 

 

	 	MADNANI LIVING TRUST
	 	 
	 	By:	 
	 	Name:   	Sean Madnani
	 	Title:	 
	 	 
	 	KEN BEYER
	 	 
	 	Ken Beyer
	 
	 	 	 
	 	ALEX PASKOFF
	 	 
	 	Alex Paskoff
	 

 

	 	MARIA MARTA R BIRGE REV TR DEC
	 	 
	 	By:	 
	 	Name:	Tag Birge
	 	Title:	 
	 	 
	 	KARIN MICHELLE HELD TRUST
	 	 
	 	By:	 
	 	Name:	Andrew Held
	 	Title:	 

 

	 	FINOVUS LLC
	 	 
	 	By:	 
	 	Name:	Steven Fivel
	 	Title:	 
	 	 
	 	ANNE T. DILLON
	 	 
	 	Anne Dillon
	 
	 	 	 
	 	BRIAN PAHUD:
	 	 
	 	Brian Pahud
	 
	 	JOEL HOFFMAN
	 	 
	 	Joel Hoffman
	 

 

 

[Signature Page to Stock Escrow Agreement]

 

     

     

    

 

	 	 
	 	BEA HOLDINGS, LLC
	 	 
	 	By:	 
	 	Name:	Bradley A. Bostic
	 	Title:	Managing Director
	 	 	 
	 	SEDD BOND HOLDINGS, LLC
	 	 
	 	By:	 
	 	Name:	David Eskenazi
	 	Title:	 
	 	
         

        ETHAN W. MEYERS TRUST

	 	 
	 	By:	 
	 	Name:	Sidney Eskenazi
	 	Title:	 
	 	 
	 	SAMANTHA H MEYERS TRUST
	 	 
	 	By:	 
	 	Name:	Sidney Eskenazi
	 	Title:	 
	 	 	 
	 	HEATHER GOODMAN
	 	 
	 	Heather Goodman
	 
	 	
         

        ALEX LAIKIN

	 	 
	 	Alex Laikin
	 

 

 

[Signature Page to Stock Escrow Agreement]

 

     

     

    

 

WITNESS the execution of this Agreement
as of the date first above written.

 

	 	CONTINENTAL STOCK TRANSFER & TRUST COMPANY
	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 

 

 

[Signature Page to Stock Escrow Agreement]

 

     

     

    

 

EXHIBIT A

 

	Name and Address of Founder	 	Number of Shares	 
	Robert J. Laikin, 8556 Oakmont Lane, Indianapolis, IN 46260	 	 318,130	 
	Zak Laikin, 8556 Oakmont Lane, Indianapolis, IN 46260	 	 	68,246	 
	Alex Laikin, 4525 Dean Martin Drive, Unit 812, Las Vegas , NV 89103	 	 	68,246	 
	Larry  Gretchen Paulson Trust, PO Box 675133, Rancho Santa Fe, CA 92067	 	 	272,987	 
	New Frontier LLC, C/o Jeff Foster, PO Box 162625 , Austin, TX 78716	 	 	272,987	 
	Hirsch Family Living Trust, 7366 Baker Lane, Sebastopol, CA 95472	 	 	90,995	 
	Mons Investments LLC, c/o Hersch Klaff, 150 Ravine Glade, Glencoe, IL 60022	 	 	136,493	 
	Cliff Holdings LLC, c/o Ryan Levy, 1340 S Michigan Ave #104, Chicago IL 60605	 	 	90,995	 
	Vince Donargo, 2002 Stanhope Street, Carmel, IN  46032	 	 	181,991	 
	Louis Conforti, 4857 South Greenwood Ave, Chicago, IL 60615	 	 	181,991	 
	Madnani Living Trust, 2009 Mount Olympus Dr, Los Angeles, CA 90046	 	 	90,995	 
	Ken Beyer, 30671 Steeplechase Dr, San Juan Capistrano, CA 92675	 	 	90,995	 
	Alex Paskoff, 11509 Willow Ridge Drive, Zionsville, IN 46077	 	 	90,995	 
	MARIA MARTA R BIRGE REV TR DEC, c/o Tag Birge, 8082 Morningside Drive, Indianapolis, IN 46240	 	 	136,493	 
	Karin Michelle Held Revocable Trust, c/o Andrew Held, 7442 Washington Blvd, Indianapolis IN 46240	 	 	90,995	 
	Finovus LLC, Attn: Steve Fivel, 312 West North St, Indianapolis, IN 46202	 	 	136,493	 
	Anne T. Dillon, 7477 N. Pennsylvania Street, Indianapolis, Indiana 46240	 	 	45,497	 
	Brian C. Pahud, c/o Landmark Properties, Inc.,9333 N. Meridian Street, Suite 350, Indianapolis, IN  46260	 	 	45,497	 
	Joel Hoffman, 123 Lily Garden Place, Alpharetta GA 30009	 	 	45,497	 
	BEA Holdings, 6100 Technology Center Drive,  Indianapolis, IN 46278, Attn: Brad Bostic	 	 	136,493	 
	Sedd Bond Holdings, LLC, Attn: David Eskenazi, 10689 North Pennsylvania Street, Indianapolis, Indiana 46280	 	 	136,493	 
	
        Ethan W. Meyers Trust, Attn: Sidney Eskenazi, 1860 Pheasant
        Run

        Longrove, Illinois 60047
	 	 	22,748	 
	
        Samantha H. Meyers Trust, Attn: Sidney Eskenazi, 1860 Pheasant
        Run

        Longrove, Illinois 60047
	 	 	22,748	 
	Heather Goodman, 101 Montgomery Street, Suite 2800 , San Francisco, CA 94104	 	 	100,000	 
	Total:	 	 	2,875,000Document

Exhibit 4.1

FIRST AMENDMENT TO RIGHTS AGREEMENT
This First Amendment to Rights Agreement (this “Amendment”) is made and entered into as of May 11, 2020 by and between Kindred Biosciences, Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, LLC (the “Rights Agent”), and is effective as of such date.
RECITALS
A. The Company and the Rights Agent are parties to a Rights Agreement dated as of May 19, 2017 (the “Rights Agreement”). Capitalized terms used and not otherwise defined in this Amendment have the meanings ascribed to such terms in the Rights Agreement.
B. Section 7(a) of the Rights Agreement provides that the Rights the Company has issued, or may subsequently issue, pursuant to the Rights Agreement will expire at the close of business on May 18, 2020.
C. The Company’s Board of Directors has determined that it is in the best interests of the Company and its stockholders to amend the Rights Agreement to cause the Rights to expire at the close of business on May 18, 2023, subject to the possibility of earlier termination or redemption in accordance with the terms of the Rights Agreement.
D. Section 27 of the Rights Agreement provides in part that “[p]rior to the time at which the Rights cease to be redeemable pursuant to Section 23, and subject to this Section 27, the Company, by action of the Board of Directors of the Company, may from time to time and in its sole and absolute discretion, and the Rights Agent will if the Company so directs, supplement or amend any provision of this Agreement in any respect without the approval of any holders of Rights or Common Stock.” Section 27 of the Rights Agreement also provides that “[u]pon the delivery of a certificate from an officer of the Company which states that the proposed supplement or amendment is in compliance with the terms of this Section 27, the Rights Agent will execute such supplement or amendment.”
E.  The Company’s Chief Executive Officer has delivered to the Rights Agent a certificate stating that this Amendment is in compliance with the terms of Section 27 of the Rights Agreement, and the Company has directed the Rights Agent to amend the Rights Agreement as set forth in this Amendment.
NOW THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt and sufficiency of which hereby are acknowledged, the Company and the Rights Agent hereby agree as follows:
Section 1. Amendment to the Rights Agreement. The first sentence of Section 7(a) of the Rights Agreement hereby is amended and restated to read in its entirety as follows:
“Except as otherwise provided herein, the Rights shall become exercisable on the Distribution Date, and thereafter the registered holder of any Right Certificate (other 
1

than Right Certificates representing Rights that have become void pursuant to Section 11(b) or that have been exchanged pursuant to Section 24) may, subject to Section 11(b), exercise the Rights evidenced thereby (except as otherwise provided herein) in whole or in part at any time after the Distribution Date upon surrender of the Right Certificate, with the form of election to purchase on the reverse side thereof duly executed, to the Rights Agent at the office of the Rights Agent designated for such purposes together with payment of the Purchase Price for each one one-thousandth of one share of the Preferred Stock as to which the Rights are exercised, at or prior to the time (the “Expiration Date”) that is the earliest of (i) the close of business on May 18, 2023 (the “Final Expiration Date”), (ii) the time at which the Rights are redeemed as provided in Section 23 (the “Redemption Date”), (iii) the closing of any merger or other acquisition transaction involving the Company pursuant to an agreement of the type described in Section 1(d)(ii)(A)(z) and Section 13(f) at which time the Rights are terminated, (iv) the time at which such Rights are exchanged as provided for in Section 24, or (v) if Stockholder Approval has not been obtained at the annual meeting of the stockholders of the Company held in 2017 (including any adjournment of such meeting), provided that this Agreement shall automatically terminate, and the Rights shall automatically expire, if Stockholder Approval is not obtained at the 2017 annual meeting (including any adjournment of such meeting).”
Section 2. Amendments to the Form of Right Certificate.
(a)The first sentence of the first paragraph of the Form of Right Certificate, which is attached as Exhibit B to the Rights Agreement, hereby is amended and restated to read in its entirety as follows:
“NOT EXERCISABLE AFTER MAY 18, 2023 OR EARLIER IF REDEEMED OR EXCHANGE OCCURS.”
(b)The first sentence of the second paragraph of the Form of Right Certificate, which is attached as Exhibit B to the Rights Agreement, hereby is amended and restated to read in its entirety as follows:
“This certifies that ___________________, or registered assigns, is the registered owner of the number of Rights set forth above, each of which entitles the owner thereof, subject to the terms, provisions and conditions of the Rights Agreement, dated as of May 19, 2017 as the same may be amended from time to time (the “Rights Agreement”), between Kindred Biosciences, Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, LLC (the “Rights Agent”), to purchase from the Company at any time after the Distribution Date (as such term is defined in the Rights Agreement) and prior to the close of business (as such term is defined in the Rights Agreement) on May 18, 2023 at the office of the Rights Agent, or its successors as Rights Agent, designated for such purposes, one one-thousandth of one fully paid and non-assessable share of the Series A Preferred Stock (the “Preferred Stock”) of the Company, at a purchase price of $25.00 per one one-thousandth of one share (the 
2

“Purchase Price”), upon presentation and surrender of this Right Certificate with the Form of Election to Purchase duly executed.”
Section 3. Amendment to the Summary of Rights to Purchase Preferred Stock. The first two sentences of the fifth full paragraph of the Summary of Rights to Purchase Preferred Stock, which is attached as Exhibit C to the Rights Agreement, hereby are amended and restated to read in their entirety as follows: 
“The Rights are not exercisable until the Distribution Date.  The Rights will expire on May 18, 2023 (the “Final Expiration Date”) unless the Final Expiration Date is extended or unless earlier redeemed or exchanged by the Company, in each case as described below.”
Section 4. Remaining Terms; Controlling Agreement. All provisions of the Rights Agreement that are not expressly amended by this Amendment shall continue in full force and effect. From and after the execution and delivery of this Amendment, any references to the Rights Agreement in the Rights Agreement or in other agreements or documents shall be deemed to refer to the Rights Agreement as amended pursuant to this Amendment. In the event of any conflict between the terms of this Amendment and the Rights Agreement, this Amendment shall control.
Section 5. Severability. If any term, provision, covenant, or restriction of this Amendment is held by a court of competent jurisdiction or other authority to be invalid, void, or unenforceable, the remainder of the terms, provisions, covenants, and restrictions of this Amendment shall remain in full force and effect and shall in no way be affected, impaired, or invalidated; provided, however, that nothing contained in this Amendment will affect the ability of the Company under the provisions of Section 27 of the Rights Agreement to supplement or amend this Amendment or the Rights Agreement to replace such invalid, null and void, or unenforceable term, provision, covenant, or restriction with a legal, valid, and enforceable term, provision, covenant, or restriction.
Section 6. Governing Law. This Amendment shall be deemed to be a contract made under the laws of the State of Delaware and for all purposes shall be governed by and construed in accordance with the laws of such state applicable to contracts to be made and performed entirely within such state.
Section 7. Counterparts. This Amendment may be executed in counterparts, each of which shall be deemed to be an original but both of which shall constitute one and the same agreement. Signatures on this Amendment executed and/or transmitted electronically or via facsimile shall have the same authority, effect, and enforceability as original signatures.
[Remainder of Page Left Intentionally Blank]

3

IN WITNESS WHEREOF, the Company and the Rights Agent have duly executed and delivered this Amendment as of the date first set forth above.
						
		KINDRED BIOSCIENCES, INC.
		
		
		By: /s/ Richard Chin    

		Name: Richard Chin, M.D.
		Title: Chief Executive Officer
		
		
		AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC
		
		
		By: /s/ Michael Nespoli    

		Name: Michael Nespoli
		Title: Executive Director
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		

4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00309-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00309-of-00352.parquet"}]]